SPECIALTY INJECTABLE GENERICS MARKET ANALYSIS

Specialty Injectable Generics MarketSize and Trends

Global Specialty Injectable Generics Market – A Cost Effective Approach in Chronic Diseases Treatment

Specialty injectable generics play a major role in advanced healthcare as they are used in treatment of various complex, life-threatening diseases such as cancer, cardiovascular diseases, HIV, hemophilia, rheumatoid arthritis, auto immune disorders, and others.

The global specialty injectable generics market size was valued at US$ 31,300 million in 2017, and is expected to exhibit a CAGR of 10.4 % over the forecast period (2018 – 2026).

Increasing incidences of chronic diseases is expected to propel growth of the global specialty injectable generics market

Specialty injectable generics are used in treatment of complex disease condition such as cancer, hemophilia, HIV, Central Nervous System (CNS)-associated disorders, and others. High prevalence of cancer is expected to drive the market growth. According to World Health Organization (WHO), in 2012, cancer was the second leading cause of morbidity and mortality worldwide, with around 14 million new cases registered in 2012. In 2015, cancer was responsible for 8.8 million deaths, worldwide. Moreover, WHO stated that the number of new cases is expected to increase by around 70% by 2030.

Furthermore, increasing incidences of HIV/AIDS is propelling growth of the specialty injectable generics market over the forecast period. According to WHO, around 36.9 billion people were diagnosed with HIV in 2017, with nearly 1 in every 25 adults in Africa living with HIV.